ChrysCap buys small stake in generics company La Renon for Rs 600 cr

Incorporated in 2007 by Pankaj Singh, La Renon is engaged in the manufacturing and marketing of branded generic formulations. ChrysCapital is close to acquiring a minority stake in La Renon Healthcare via secondary sale of shares, at a valuation of Rs 6,500 crore ($800 million), ET first reported on February 12.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/ND62kWI
via IFTTT